摘要
Abacavir/lamivudine is a combination of two synthetic nucleoside analogues which is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus(HIV)infection in adults and adolescents[1].A generic product of abacavir/lamivudine has been developed with lower price by the Government Pharmaceutical Organization(GPO)to be an alternative choice of related physicians and patients who will gain access to the lower price medicines at the same quality and safety as the reference product.
